From: Mortality in hospitalized patients with tuberculous meningitis
Total (n = 263) | HIV Positive (n = 100) | HIV Negative (n = 163) | p-value | |
---|---|---|---|---|
Age (years)a | 35 (18–84) | 35 (18–74) | 35 (18–84) | 0.899 |
Male | 191 (72.6%) | 81 (81.0%) | 110 (67.4%) | 0.010 |
TB history | 63 (24.0%) | 34 (34.0%) | 29 (17.8%) | 0.002 |
MDR-TB history | 6 (2.28%) | 5 (5.0%) | 1 (0.3%) | 0.030 |
TB contact | 70 (26.7%) | 21 (21.0%) | 49 (30.1%) | 0.116 |
Alcoholism / Drug addiction | 60 (22.8%) | 34 (34.0%) | 26 (15.9%) | 0.001 |
Symptoms > 7 days | 199 (76.1%) | 82 (82.0%) | 117 (71.8%) | 0.075 |
Weight loss | 129 (50.9%) | 59 (59.6%) | 70 (45.5%) | 0.029 |
Headache | 200 (79.1%) | 81 (81.0%) | 119/154 (77.3%) | 0.431 |
Fever | 182 (72.0%) | 72 (72.0%) | 110/154 (71.4%) | 0.886 |
Altered level of Consciousness | 173 (68.1%) | 58 (58.0%) | 115/155 (74.2%) | 0.013 |
Focal neurologic deficits | 91 (36.0%) | 31 (31.3%) | 60 (38.9%) | 0.020 |
BMRC stage | ||||
I | 93 (35.3%) | 39 (39.0%) | 54 (33.1%) | 0.502 |
II | 133 (50.6%) | 46 (46.0%) | 87 (53.4%) | |
III | 37 (14.1%) | 15 (15.0%) | 22 (13.5%) | |
WBCb > 10,000 cells/uL | 74/253 (29.3%) | 15/99 (15.2%) | 59/154 (38.3%) | < 0.001 |
Hyponatremia | 146/219 (66.7%) | 64/85 (75.3%) | 82/134 (61.2%) | 0.039 |
CD4 counta | 60 (1–874) | |||
CD4 < 200 | 64/81 (79.0%) | |||
Detectable HIV Viral load | 76/77 (98.7%) | |||
CSF Analysis | ||||
Proteina | 213 (10–6000) | 226 (12–1200) | 210 (10–6000) | 0.550 |
Glucosea | 32 (10–118) | 33.2 (13.5–82) | 31 (10–118) | 0.595 |
Leucocytesa | 80 (1–3808) | 56 (1–1550) | 90 (1–3808) | 0.040 |
Mononuclear cells (%)a | 98 (5–100) | 100 (15–100) | 95 (5–100) | 0.010 |
ADAa | 10 (0.8–76.1) | 9.8 (0.9–53.3) | 10 (0.9–76.1) | 0.974 |